German nation-wide in-patient treatment of abdominal aortic aneurysm — trends between 2005 and 2019 and impact of the SARS-CoV-2 pandemic

  • Purpose Aim of this study was to analyze hospitalizations due to ruptured and non-ruptured abdominal aortic aneurysms (rAAA, nrAAA) in Germany between 2005 and 2021 to determine long-term trends in treatment and the impact of the SARS-CoV-2 pandemic. Materials and Methods Fully anonymized data were available from the research data center (RDC) of the German Federal Statistical Office (Destatis). All German hospitalizations with the ICD-10 code “I71.3, rAAA” and “I71.4, nrAAA” in 2005 and 2010–2021 were analyzed. Results We report data of a total of 202,951 hospitalizations. The number of hospitalizations increased from 2005 to 2019 (14,075 to 16,051, + 14.0%). The rate of open repair (OR) constantly decreased, whereas the rate of endovascular aortic repair (EVAR) increased until 2019. During the pandemic, the number of hospitalizations due to nrAAA dropped from 13,887 (86.5%) in 2019 to 11,278 (85.0%) in 2021. The strongest decrease of hospitalizations for AAA was observedPurpose Aim of this study was to analyze hospitalizations due to ruptured and non-ruptured abdominal aortic aneurysms (rAAA, nrAAA) in Germany between 2005 and 2021 to determine long-term trends in treatment and the impact of the SARS-CoV-2 pandemic. Materials and Methods Fully anonymized data were available from the research data center (RDC) of the German Federal Statistical Office (Destatis). All German hospitalizations with the ICD-10 code “I71.3, rAAA” and “I71.4, nrAAA” in 2005 and 2010–2021 were analyzed. Results We report data of a total of 202,951 hospitalizations. The number of hospitalizations increased from 2005 to 2019 (14,075 to 16,051, + 14.0%). The rate of open repair (OR) constantly decreased, whereas the rate of endovascular aortic repair (EVAR) increased until 2019. During the pandemic, the number of hospitalizations due to nrAAA dropped from 13,887 (86.5%) in 2019 to 11,278 (85.0%) in 2021. The strongest decrease of hospitalizations for AAA was observed during the first wave of the SARS-CoV-2-pandemic in spring 2020 (-25.5%). Conclusion Over the past decades, we observed an increasing number of hospitalizations due to AAA accompanied by a shift from OR to EVAR especially for nrAAA. During the lockdown measures due to the SARS-CoV-2-pandemic, a decrease in hospitalizations for nrAAA (but not for rAAA) was shown in 2020 and furthermore in 2021 with no rebound of treatment of nrAAA suggesting an accumulation of untreated AAA with a potentially increased risk of rupture.show moreshow less

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Stefanie Bette, Josua A. Decker, Sebastian ZerwesORCiDGND, Yvonne Gosslau, Dominik Liebetrau, Alexander Hyhlik-DuerrORCiDGND, Florian Schwarz, Thomas J. KroenckeORCiDGND, Christian Scheurig-Muenkler
URN:urn:nbn:de:bvb:384-opus4-1082636
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/108263
ISSN:2520-8934OPAC
Parent Title (English):CVIR Endovascular
Publisher:Springer Science and Business Media LLC
Type:Article
Language:English
Date of first Publication:2023/08/29
Publishing Institution:Universität Augsburg
Release Date:2023/10/11
Tag:Cardiology and Cardiovascular Medicine; Radiology, Nuclear Medicine and imaging
Volume:6
Issue:1
First Page:44
DOI:https://doi.org/10.1186/s42155-023-00389-4
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Diagnostische und Interventionelle Radiologie
Medizinische Fakultät / Lehrstuhl für Gefäßchirurgie
Fakultätsübergreifende Institute und Einrichtungen / Zentrum für Advanced Analytics and Predictive Sciences (CAAPS)
Nachhaltigkeitsziele
Nachhaltigkeitsziele / Ziel 3 - Gesundheit und Wohlergehen
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY 4.0: Creative Commons: Namensnennung (mit Print on Demand)